Vast Opportunity of Pharma Contract Manufacturing - PharmaBizConnect
The trend of Pharma Third Party Contract Manufacturing is getting popular from last few years, Third Party Contract Manufacturing means getting your Trade Name Pharmaceuticals Brands Manufactured from outsourced Manufacturers so as on the Box it would be mentioned as Manufacturer by outsourced Manufacturer and Marketed by your company.
As the persons associated with Pharma Business believe in promoting their own brands in the Pharma market which actually means achieving a dream of owning a Pharma Business. One can easily do you even without investing heavily in the infrastructure of a manufacturing plant. Marketing Companies then can concentrate on the skills which they are good at like marketing and leave Manufacturer to do the manufacturing part, this way there is a harmony of efforts and results are encouraging. The big Pharma Industries or organizations, who own their manufacturing unit, do manufacturing for small as well as large enterprises with their suggested brand name on the basis of a contract. It is basically the outsourcing of Production of health-care products. Our country has the superior edge over some other countries in terms of Pharma Contract Manufacturing as there is ready availability of the trained human resource, growing domestic market and the opening of the international market. It is expected that Third Party Contract Manufacturing is around 35000 cr market. Domestic Production takes close to around 35-45 days from approval of design to final packing and repeats orders take around 30 days as packing material is readily available. Minimum batch size is around 500 to 1000 boxes and Syrups around 3000 to 5000 bottles, Ointment and Creams approx 5000 to 10000 Tubes. Rates are dependent on quantity though the difference is not large it may vary between 3-5 % not beyond that. The main concern of a customer or client who wants marketing of his own brands in Pharma is to select the Manufacturer with whom you can manufacture your pharmaceutical products. The first step is to